Could beetroot juice be used to treat fetal growth restriction?
-
Authors list
Dr Elizabeth Cottrell, Dr Teresa Tropea, Professor Colin Sibley, Dr Susan Greenwood, Dr Mark Wareing, Catherine Chmiel, Dr Laura Ormesher, Dr Ed Johnstone, Dr Jenny Myers
-
Research centre
This research project is now complete.
Why was this research needed?
Fetal growth restriction (FGR) is when a baby’s growth in the womb slows or stops, and affects around 5% of all pregnancies. Often when this happens, there isn’t enough blood flowing across the placenta, which means the baby can’t get the food and oxygen it needs to grow. Currently, there is no treatment for FGR: early delivery is the only option.
Our researchers are trying to change this, by trying to find ways to improve the blood flow to the placenta.
What happened in this project?
Nitric oxide is a small molecule made throughout the body that makes our blood vessels get wider, allowing blood to flow more easily. It is particularly important in making sure enough blood flows across the placenta during pregnancy. Having high blood pressure can reduce placental blood flow.
Nitrate is a nutrient which is abundant in green leafy vegetables and beetroot. Recently, scientists have shown that nitrate can be ‘activated’ in the body to increase levels of nitric oxide. Studies in non-pregnant humans and animals have shown that supplementing the diet with nitrate can increase blood flow and reduce blood pressure.
Researchers funded by Tommy’s and the British Heart Foundation have recently completed their study into the effects of beetroot juice, which has high levels of nitrate. In one part of the study, with pregnant mice with reduced placental blood flow, they demonstrated that beetroot juice can increase blood flow to the uterus.
In the other part of their study, pregnant women with high blood pressure were given either beetroot juice that contains nitrate, or a placebo (an identical juice with the nitrate removed). They found that nitrate supplementation significantly lowered blood pressure in some women, but not all. Importantly, amongst the 40 women that completed the trial, almost all said they would be willing to drink beetroot juice in the future if it would be of benefit.
What’s next for the study?
The results suggest that a dietary nitrate supplement could help to control blood pressure in pregnant women. However, further studies are now required to confirm this finding, and to understand why not all the women in the study benefitted from the beetroot juice supplement. We are now funding a new research project to understand whether bacteria present in the mouth may have a role to play in whether nitrate affects blood pressure.
Ultimately, these studies could provide an easy way for pregnant women to control high blood pressure, increasing blood flow to the placenta and reducing the risk of fetal growth restriction.
Research papers
Ormesher L, Myers JE, Chmiel C, Wareing M, Greenwood SL, Tropea T, Lundberg JO, Weitzberg E, Nihlen C, Sibley CP, Johnstone ED, Cottrell EC. Effects of dietary nitrate supplementation, from beetroot juice, on blood pressure in hypertensive pregnant women: A randomised, double-blind, placebo-controlled feasibility trial. Nitric oxide: biology and chemistry. Nov 1 2018;80:37-44.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. If you're interested in being kept updated about our research and news from Tommy's, click here.
Read more on this topic
-
Research into stillbirth
When a baby dies after 24 weeks of gestation, it is called a stillbirth. Nearly 3000 families a year get the devastating news that their baby is not alive. Our research is helping to change this. -
Diabetes, fetal growth and stillbirth
Women suffering from type 1 or type 2 diabetes are more likely to suffer from stillbirths. We want to help people with diabetes to have healthy pregnancies. -
Preventing stillbirth: the role of the immune system in rejecting the placenta
Tommy’s are studying chronic histiocytic intervillositis, which causes the immune system to reject the placenta, leading to stillbirth or miscarriage. -
Understanding how the womb lining matures during pre-eclampsia
Pre-eclampsia can lead to health problems and sometimes stillbirth, but we don’t know enough about what causes it. Our researchers are studying how the lining of the womb develops during early pregnancy. This could reveal new ways to prevent pre-eclampsia and reduce the risk of stillbirth. -
The AFFIRM trial for prevention of stillbirth
Researchers supported by Tommy’s are looking at whether a package of care and resources for pregnant women can help stop stillbirths. -
Homing peptides: targeting drugs to the placenta
Drugs which could help prevent pregnancy complications can’t reach the placenta effectively. Tommy’s researchers are making use of ‘homing peptides’ to deliver drugs directly to the placenta. This work could help to prevent pregnancy complications and stillbirth. -
Stillbirth and fetal free haemoglobin
Researchers supported by Tommy’s have found that the substance that usually carries oxygen around our blood may have harmful effects on the baby when it escapes from red blood cells. -
ReMIT-2 – a feasibility study for spotting the early signs of complications
We need better ways to spot the early signs of pregnancy complications. The ReMIT-2 study laid the foundations for a large clinical trial of a blood test which could predict which women need urgent care to prevent stillbirth.